Cargando…

Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration

BACKGROUND/AIMS: Real-life anti-vascular endothelial growth factor (VEGF) therapy use in patients with wet age-related macular degeneration (wAMD) was assessed in a retrospective, observational study in Canada, France, Germany, Ireland, Italy, the Netherlands, UK and Venezuela. METHODS: Medical reco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holz, Frank G, Tadayoni, Ramin, Beatty, Stephen, Berger, Alan, Cereda, Matteo G, Cortez, Rafael, Hoyng, Carel B, Hykin, Philip, Staurenghi, Giovanni, Heldner, Stephanie, Bogumil, Timon, Heah, Theresa, Sivaprasad, Sobha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316940/ https://www.ncbi.nlm.nih.gov/pubmed/25193672 http://dx.doi.org/10.1136/bjophthalmol-2014-305327

Ejemplares similares

Key drivers of visual acuity gains in neovascular age-related macular degeneration in real life: findings from the AURA study
por: Holz, Frank G, et al.
Publicado: (2016)

Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study
por: Holz, F G, et al.
Publicado: (2016)

Pegaptanib sodium for neovascular age-related macular degeneration: clinical experience in the UK
por: Sivaprasad, Sobha, et al.
Publicado: (2008)

Characterisation of macular neovascularisation subtypes in age-related macular degeneration to optimise treatment outcomes
por: Mathis, Thibaud, et al.
Publicado: (2022)

Caregiver Burden in Patients Receiving Ranibizumab Therapy for Neovascular Age Related Macular Degeneration
por: Gohil, Rishma, et al.
Publicado: (2015)

A retrospective study of the real-life utilization and effectiveness of ranibizumab therapy for neovascular age-related macular degeneration in the UK
por: Hykin, Philip, et al.
Publicado: (2016)

Treatment satisfaction of patients undergoing ranibizumab therapy for neovascular age-related macular degeneration in a real-life setting
por: Gohil, Rishma, et al.
Publicado: (2016)

Role of pegaptanib sodium in the treatment of neovascular age-related macular degeneration
por: Sivaprasad, Sobha
Publicado: (2008)

An exploratory study evaluating the effects of macular carotenoid supplementation in various retinal diseases
por: Crosby-Nwaobi, Roxanne, et al.
Publicado: (2016)

Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial
por: Garweg, Justus G., et al.
Publicado: (2022)

Three-Year Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting
por: Eleftheriadou, Maria, et al.
Publicado: (2018)

Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration
por: Chandra, Shruti, et al.
Publicado: (2020)

Visual outcome of ranibizumab therapy for neovascular age related macular degeneration in the black population: a report of five cases
por: Vemala, Roopa, et al.
Publicado: (2010)

Structural and Functional Measures of Efficacy in Response to Bevacizumab Monotherapy in Diabetic Macular Oedema: Exploratory Analyses of the BOLT Study (Report 4)
por: Sivaprasad, Sobha, et al.
Publicado: (2013)

Watching synchronous mitochondrial respiration in the retina and its instability in a mouse model of macular degeneration
por: Kaynezhad, Pardis, et al.
Publicado: (2021)

Health-related quality of life, visual function and treatment satisfaction following intravitreal dexamethasone implant for diabetic macular edema
por: Ramu, Jayashree, et al.
Publicado: (2017)

Imaging of Wet Age-Related Macular Degeneration
por: Kenan, Damer
Publicado: (2016)

Correction: Structural and Functional Measures of Efficacy in Response to Bevacizumab Monotherapy in Diabetic Macular Oedema: Exploratory Analyses of the BOLT Study (Report 4)
por: Sivaprasad, Sobha, et al.
Publicado: (2013)

Risk factors for progression of age‐related macular degeneration
por: Heesterbeek, Thomas J, et al.
Publicado: (2020)

Scotopic thresholds on dark-adapted chromatic perimetry in healthy aging and age-related macular degeneration
por: Grewal, Manjot Kaur, et al.
Publicado: (2021)

Quantitative Autofluorescence in Non-Neovascular Age Related Macular Degeneration
por: Chandra, Shruti, et al.
Publicado: (2023)

The clinical relevance of ultra-widefield angiography findings in patients with central retinal vein occlusion and macular oedema receiving anti-VEGF therapy
por: Nicholson, Luke, et al.
Publicado: (2021)

Mapping From Visual Acuity to EQ-5D, EQ-5D With Vision Bolt-On, and VFQ-UI in Patients With Macular Edema in the LEAVO Trial
por: Pennington, Becky M., et al.
Publicado: (2020)

Macular Edema: Drying Is Not Repairing
por: Tadayoni, Ramin
Publicado: (2013)

CLINICAL CHARACTERISTICS AND OUTCOME OF POSTERIOR CYSTOID MACULAR DEGENERATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
por: Mohabati, Danial, et al.
Publicado: (2020)

Nutritional Risk Factors for Age-Related Macular Degeneration
por: Ersoy, Lebriz, et al.
Publicado: (2014)

Optical coherence tomography imaging biomarkers associated with neovascular age-related macular degeneration: a systematic review
por: Hanson, Rachel L. W., et al.
Publicado: (2022)

Pegaptanib in the treatment of wet, age-related macular degeneration
por: Vinores, Stanley A
Publicado: (2006)

Bevasiranib for the Treatment of Wet, Age-Related Macular Degeneration
por: Garba, Adinoyi O., et al.
Publicado: (2010)

Microcurrent stimulation in the treatment of dry and wet macular degeneration
por: Chaikin, Laurie, et al.
Publicado: (2015)

Future Therapies of Wet Age-Related Macular Degeneration
por: Ishikawa, Makoto, et al.
Publicado: (2015)

Near-infrared reflectance imaging of neovascular age-related macular degeneration
por: Theelen, Thomas, et al.
Publicado: (2009)

Corrigendum to “Nutritional Risk Factors for Age-Related Macular Degeneration”
por: Ersoy, Lebriz, et al.
Publicado: (2016)

Genetics of Unilateral and Bilateral Age-Related Macular Degeneration Severity Stages
por: Schick, Tina, et al.
Publicado: (2016)

ASSESSMENT OF ANATOMICAL AND FUNCTIONAL OUTCOMES WITH OCRIPLASMIN TREATMENT IN PATIENTS WITH VITREOMACULAR TRACTION WITH OR WITHOUT MACULAR HOLES: Results of OVIID-1 Trial
por: Tadayoni, Ramin, et al.
Publicado: (2019)

Genetic Risk in Families with Age-Related Macular Degeneration
por: de Breuk, Anita, et al.
Publicado: (2021)

Geographic distribution of rare variants associated with age-related macular degeneration
por: Geerlings, Maartje J., et al.
Publicado: (2018)

Indicators of Visual Prognosis in Diabetic Macular Oedema
por: Sen, Sagnik, et al.
Publicado: (2021)

Predictors of Visual Acuity Outcomes after Anti–Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion
por: Sen, Piyali, et al.
Publicado: (2021)

Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
por: García-Layana, Alfredo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jmrq6aqnlqakpsmg775m1rh3gn